Biography
Katrin Burkart, PhD, is an Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In this role, she works on the Global Burden of Disease (GBD) project, conducting research on environmental risks and methods to include exposure to suboptimal temperature. Dr. Burkart is also working on projections of future temperature-related mortality under climate and population change scenarios. In addition to accounting for rising temperatures, she is particularly interested in incorporating the dynamics of global change, especially demographic and epidemiological change as well as urbanization into her estimations and projections.
Before coming to the University of Washington, Dr. Burkart was a Postdoctoral Research Scientist in the Department of Environmental Health Sciences at the Mailman School of Public Health at Columbia University in New York. Dr. Burkart received her doctorate from the Humboldt Universität zu Berlin, Germany, where she conducted research on the short- and long-term impacts of temperature and thermal conditions on human mortality in Bangladesh. She is particularly interested in understanding how temperature impacts are modified by regional, spatial, or population-specific characteristics. Dr. Burkart has published several papers on effect modifications by demographic characteristics, such as age and socioeconomic status, as well as intra-urban and urban-rural differences. In recent studies, she highlighted interactive effects between air pollution and high temperatures and pointed at the role of urban vegetation in heat effect mitigation.
IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.
GBD 2019 Indonesia Subnational Collaborators. The state of health in Indonesia’s provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Global Health. 11 October 2022. doi: 10.1016/S2214-109X(22)00371-0.
Zheng P, Afshin A, Biryukov S, et al. The Burden of Proof studies: assessing the evidence of risk. Nature Medicine. 10 October 2022. doi: 10.1038/s41591-022-01973-2.
GBD 2019 Healthcare Access and Quality Collaborators. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Global Health. 6 October 2022. doi: 10.1016/S2214-109X(22)00429-6.
GBD 2019 LRI Collaborators. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. 11 August 2022. doi: 10.1016/S1473-3099(22)00510-2.
GBD 2019 Diabetes and Air Pollution Collaborators. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. The Lancet Planetary Health. 6 July 2022. doi:/10.1016/S2542-5196(22)00122-X.
GBD 2019 Adolescent Transport and Unintentional Injuries Collaborators. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. The Lancet Public Health. 29 June 2022. doi: 10.1016/S2468-2667(22)00134-7.
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 6 January 2022. doi: 10.1016/ S2468-2667(21)00249-8.
GBD 2019 Adolescent Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Oncology. 03 December 2021. doi: 10.1016/S1470-2045(21)00581-7.
GBD 2019 Police Violence US Subnational Collaborators. Fatal police violence by race and state in the USA, 1980-2019: a network meta-regression. The Lancet. 30 September 2021. doi: 10.016/S0140-6736(21)01609-3
Ghosh R, Causey K, Burkart K, Wozniak S, Cohen A, Brauer M. Ambient and household PM2.5 pollution and adverse perinatal outcomes: A meta- regression and analysis of attributable global burden for 204 countries and territories. PLoS Medicine. 28 September 2021. doi:10.1371/journal.pmed.1003718.
GBD 2019 HIV Collaborators. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. The Lancet HIV. 27 September 2021. doi: 10.1016/S2352-3018(21)00152-1.
Burkart KG, Brauer M, Aravkin AY, Godwin WW, Hay SI, He J, Iannucci VC, Larson SL, Lim SS, Liu J, Murray CJL, Zheng P, Zhou M, Stanaway JD. Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study. The Lancet. 19 August 2021. doi: 10.1016/S0140-6736(21)01700-1.
GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. The Lancet. 17 August 2021. doi: 10.1016/S0140-6736(21)01207-1.
GBD 2019 Chewing Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Public Health. 27 May 2021. doi: 10.1016/S2468-2667(21)00065-7.
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 27 May 2021. doi: 10.1016/S0140-6736(21)01169-7.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. The Lancet Planetary Health. 21 December 2020. doi:10.1016/S2542-5196(20)30298-9.
India State-Level Disease Burden Initiative Air Pollution Collaborators. The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. The Lancet Planetary Health. 5 Dec 2018. doi: https://doi.org/10.1016/S2542-5196(18)30261-4